Skip to main content
Cold and flu season Temporada de influenza y resfriados

ALERT: Stay healthy this cold and flu season! Learn more

ALERTA: ¡Mantente sano durante esta temporada de influenza y resfriados! Más información

New Website! ¡Nuevo sitio web!

ALERT: We have made the Texas Children’s Health Plan website even easier to use! Click here to learn more.

ALERTA: ¡Ahora el sitio web de Texas Children’s Health Plan es aún más sencillo de usar! Haz clic aquí para más información.

Enfamil shortage updates Escasez de Enfamil Reguline

ALERT: Shortage of Enfamil products until October 31, 2024. Learn more.

ALERTA: Escasez de productos de Enfamil hasta el 31 de octubre de 2024. Más información.

Change Healthcare Incident Change Healthcare incidente

Maximum Allowable Update for Non-Risk Based Drugs Billed With ‘Unclassified’ Procedure Codes

Date: June 12, 2024

Attention: All Providers

Call to action: The Texas Health and Human Services Commission (HHSC) would like to disclose the maximum allowable reimbursement for Non-Risk drugs currently payable under an ‘Unclassified’ procedure code as referenced in the National Drug Code to Healthcare Common Procedure Coding System (NDC to HCPCS) crosswalk.

How this impacts providers: HHSC bases the pricing for an outpatient medical claim for an ‘Unclassified’ procedure code on the lesser of the manufacturer’s suggested retail price minus 18% or Average Wholesale Price (AWP) minus 10.5%. Currently, two Non-Risk drugs are billed with the ‘Unclassified’ procedure code. The effective date and current maximum allowable reimbursement rate for Skysona and Zynteglo are in the table below.

NDCDrug NameEffective DateTerm DateDrug TypeCodeMax Rate
73554211101SKYSONA INFUSION BAG-CASSETTE7/1/202312/31/9999CADJ3590$3,222,000
73554311101ZYNTEGLO INFUSION BAG-CASSETTE7/1/202312/31/9999CADJ3590$3,007,200

The qualified treatment center must send the prescription to the manufacturer-authorized specialty pharmacy. The pharmacy will process the claim for the drug through medical benefits using the ‘Unclassified’ procedure code.

As a reminder, HHSC limits Non-Risk payments to the actual amounts paid to providers for the drug’s ingredient cost (up to the fee-for-service reimbursement amount). TCHP requires the facility to submit an invoice.

Next step for Providers: Prescribers should share this communication with their staff. Provider must submit documentation (such as office chart notes, lab results, other pertinent clinical information, etc.) supporting that the member has met all appropriate criteria for medication approval.

Related Provider Alerts:

https://www.thecheckup.org/2023/08/28/provider-alert-non-risk-based-status-for-zynteglo-began-july-1-2023/
https://www.thecheckup.org/2023/08/28/provider-alert-hhsc-to-add-skysona-as-medicaid-and-chip-benefit-july-1-2023-prior-authorization-effective-september-1-2023/


If you have any questions, please email TCHP Pharmacy at:
 tchppharmacy@texaschildrens.org.

For access to all provider alerts,log into:
www.thecheckup.org or www.texaschildrenshealthplan.org/for-providers.